Pharmacokinetics of itraconazole oral solution in neutropenic children during long-term prophylaxis. 2001

C Schmitt, and Y Perel, and J L Harousseau, and S Lemerle, and E Chwetzoff, and J P le Moing, and J C Levron
Hôpital d'Enfants, Vandoeuvre les Nancy, France.

We investigated the pharmacokinetics and safety of an oral solution of itraconazole in two groups of neutropenic children stratified by age. Effective concentrations of itraconazole in plasma were reached quickly and maintained throughout treatment. The results indicate a trend toward higher concentrations of itraconazole in plasma in older children.

UI MeSH Term Description Entries
D008134 Long-Term Care Care over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care. Care, Long-Term,Long Term Care
D009503 Neutropenia A decrease in the number of NEUTROPHILS found in the blood. Neutropenias
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D017964 Itraconazole A triazole antifungal agent that inhibits cytochrome P-450-dependent enzymes required for ERGOSTEROL synthesis. Orungal,R-51211,Sporanox,R 51211,R51211
D019072 Antibiotic Prophylaxis Use of antibiotics before, during, or after a diagnostic, therapeutic, or surgical procedure to prevent infectious complications. Antibiotic Premedication,Premedication, Antibiotic,Antibiotic Premedications,Premedications, Antibiotic,Prophylaxis, Antibiotic

Related Publications

C Schmitt, and Y Perel, and J L Harousseau, and S Lemerle, and E Chwetzoff, and J P le Moing, and J C Levron
January 1999, Mycoses,
C Schmitt, and Y Perel, and J L Harousseau, and S Lemerle, and E Chwetzoff, and J P le Moing, and J C Levron
December 1999, Mycoses,
C Schmitt, and Y Perel, and J L Harousseau, and S Lemerle, and E Chwetzoff, and J P le Moing, and J C Levron
February 1997, AIDS patient care and STDs,
C Schmitt, and Y Perel, and J L Harousseau, and S Lemerle, and E Chwetzoff, and J P le Moing, and J C Levron
January 1999, Mycoses,
C Schmitt, and Y Perel, and J L Harousseau, and S Lemerle, and E Chwetzoff, and J P le Moing, and J C Levron
December 1999, Mycoses,
C Schmitt, and Y Perel, and J L Harousseau, and S Lemerle, and E Chwetzoff, and J P le Moing, and J C Levron
February 1998, Antimicrobial agents and chemotherapy,
C Schmitt, and Y Perel, and J L Harousseau, and S Lemerle, and E Chwetzoff, and J P le Moing, and J C Levron
April 2016, Journal of feline medicine and surgery,
C Schmitt, and Y Perel, and J L Harousseau, and S Lemerle, and E Chwetzoff, and J P le Moing, and J C Levron
May 2008, International journal of antimicrobial agents,
C Schmitt, and Y Perel, and J L Harousseau, and S Lemerle, and E Chwetzoff, and J P le Moing, and J C Levron
January 2013, Clinica chimica acta; international journal of clinical chemistry,
C Schmitt, and Y Perel, and J L Harousseau, and S Lemerle, and E Chwetzoff, and J P le Moing, and J C Levron
December 2001, Journal of clinical pharmacology,
Copied contents to your clipboard!